Cell & Gene Therapy International Europe 2025

Conference Details

Date: 01 December 2025

Time: To be announced

Duration: 3 days

Location: Berlin, Germany

Cost: £ 699 - £ 1299

Organiser: Informa Connect

Conference Website

Conference Description

Cell & Gene Therapy International Europe Conference & Exhibit Hall

Join Europe's most influential cell and gene therapy innovators as they navigate regulatory challenges, address manufacturing hurdles, and accelerate therapeutic development beyond CAR-T and AAV therapies. Connect with decision-makers from leading pharmaceutical organisations, innovative CGT biotech companies, research centres and emerging start-ups collectively tackling the pressing challenges in scaling production and improving patient access to advanced therapies throughout Europe.

Brilliant Minds Behind Breakthrough Innovations: Our 2025 Speaker Showcase

Cell & Gene Therapy International Europe features thought leaders and therapeutic developer innovators who are actively shaping the industry's future. We provide unparalleled access to cutting-edge research, regulatory insights, and manufacturing expertise specifically tailored to the European advanced therapy landscape.

Streamline Operations, Lower Costs & Scale Better -Advancing Cell & Gene Therapy Access

Explore the full spectrum of advanced therapies from development to production, learn how to optimise every phase and expand patient access like never before!

Your ticket includes access to all conference sessions, interactive discussions, and networking opportunities, plus 12 months of on-demand recordings to enhance your learning.

Cell Therapy

Discover cutting-edge solutions to revolutionise your autologous & allogeneic cell therapy manufacturing, from automated processes, decentralised manufacturing to rapid scale-up strategies with reduced costs and increased product quality.

Boost Efficiency with the Cell Therapy Agenda

Gene Therapy

Accelerate gene therapy production with breakthrough upstream and downstream innovations. Fast-track approvals through innovative analytics, process control and characterisation without compromising quality.

Scale Smart with the Gene Therapy Agenda